UBS Group AG - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 49 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$2,399
-93.6%
475
-93.7%
0.00%
Q2 2023$37,725
+135.9%
7,500
+188.5%
0.00%
Q1 2023$15,990
-46.7%
2,600
-73.7%
0.00%
Q3 2022$30,000
+100.0%
9,883
+295.5%
0.00%
Q1 2022$15,000
-65.9%
2,499
-15.2%
0.00%
Q3 2021$44,000
-80.4%
2,946
-97.2%
0.00%
Q4 2020$224,000
-7.1%
104,890
+1.3%
0.00%
Q3 2020$241,000
+760.7%
103,579
+169.7%
0.00%
Q1 2020$28,000
+100.0%
38,400
+604.6%
0.00%
Q4 2019$14,000
+55.6%
5,450
+244.3%
0.00%
Q2 2019$9,0001,5830.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,499,149$18,814,0003.39%
New Leaf Venture Partners, L.L.C. 117,242$7,975,0002.05%
Worth Venture Partners, LLC 348,703$4,376,0001.63%
INSPIRION WEALTH ADVISORS, LLC 253,262$3,178,0000.78%
EAM Global Investors LLC 187,900$2,358,0000.65%
EAM Investors, LLC 279,613$3,509,0000.54%
ACT CAPITAL MANAGEMENT, LLC 45,000$565,0000.29%
Andesa Financial Management Inc. 33,310$418,0000.13%
Monashee Investment Management LLC 80,000$1,004,0000.12%
Sofinnova Investments, Inc. 142,635$1,790,0000.10%
View complete list of PDS BIOTECHNOLOGY CORP shareholders